A CBS News report highlights a record number of immigration detainees voluntarily leaving the United States, with the figure reaching 28% under President Trump's second term. This marks an increase from previous years, including 21% during his first term. The trend is attributed to stricter enforcement measures.

February 13, 2026 Reported by AI Fact checked

Seven members of the American Society of Plastic Surgeons’ Gender Surgery Task Force sent an open letter asking how the group developed a February 3 position statement advising surgeons to delay gender-related chest, genital and facial procedures until patients are at least 19. ASPS told The Daily Wire it viewed the letter as based on misunderstandings it is working to clarify.

A new entity called Freedom 250—described as a wholly owned subsidiary of the National Park Foundation—has begun rolling out plans tied to the United States’ 250th anniversary in 2026, including mobile museum exhibits and a major July 4 event on the National Mall. The shift has fueled criticism from some observers who say it is sidelining, or at least competing with, the congressionally created U.S. Semiquincentennial Commission and its nonprofit support organization, America250.

February 13, 2026 Reported by AI Fact checked

About a year after Robert F. Kennedy Jr. took office as U.S. secretary of health and human services, the CDC has rolled back several universal childhood immunization recommendations, and the administration has moved to claw back pandemic-era public health funds and unwind federal investments in mRNA vaccine development—steps that critics say conflict with Kennedy’s confirmation-hearing assurances on vaccines and vaccine-related funding.

A new report from Alliance for Consumers Action argues that activist networks and aligned legal groups are increasingly using lawsuits and settlements to secure policy changes they could not obtain through elections or legislation. The 19-page document, titled “Lawfare in America,” describes the trend as “woke lawfare” and highlights employment and environmental cases it says have produced broad, forward-looking requirements for companies and government entities.

February 13, 2026 Reported by AI

Researchers are exploring CAR T-cell therapy to slow the advancement of amyotrophic lateral sclerosis (ALS) by targeting overactive immune cells in the brain. The approach aims to reduce neuron damage without curing the disease. Early studies suggest potential benefits for other neurodegenerative conditions as well.